Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lubov Timchenko

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|September 23, 2022
Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2Lubov Timchenko
The International Journal of Biochemistry & Cell Biology|June 26, 2013
Molecular mechanisms of muscle atrophy in myotonic dystrophiesLubov Timchenko
International Journal of Molecular Sciences|December 28, 2019
Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1Lubov Timchenko
Nature Genetics|August 31, 2006
Reversal of fortuneLubov Timchenko
International Journal of Molecular Sciences|October 14, 2022
Myotonic Dystrophy: From Molecular Pathogenesis to TherapeuticsLubov Timchenko
Current Genomics|October 2, 2010
Myotonic dystrophies 1 and 2: complex diseases with complex mechanismsBenedikt Schoser, Lubov Timchenko
Ageing Research Reviews|March 27, 2012
The role of CUGBP1 in age-dependent changes of liver functionsKarlie Jones, Lubov Timchenko, Nikolai A Timchenko
Seminars in Cancer Biology|September 21, 2010
Intracellular signaling and hepatocellular carcinomaPolina Iakova, Lubov Timchenko, Nikolai A Timchenko
Rare Diseases (Austin, Tex.)|July 9, 2014
GSK3β is a new therapeutic target for myotonic dystrophy type 1Christina Wei, Karlie Jones, Nikolai A Timchenko, et al.
Aging|February 17, 2010
GSK3beta and aging liverJingling Jin, Guo-Li Wang, Lubov Timchenko, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|September 23, 2022
Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2Lubov Timchenko
The International Journal of Biochemistry & Cell Biology|June 26, 2013
Molecular mechanisms of muscle atrophy in myotonic dystrophiesLubov Timchenko
International Journal of Molecular Sciences|December 28, 2019
Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1Lubov Timchenko
Nature Genetics|August 31, 2006
Reversal of fortuneLubov Timchenko
International Journal of Molecular Sciences|October 14, 2022
Myotonic Dystrophy: From Molecular Pathogenesis to TherapeuticsLubov Timchenko
Current Genomics|October 2, 2010
Myotonic dystrophies 1 and 2: complex diseases with complex mechanismsBenedikt Schoser, Lubov Timchenko
Ageing Research Reviews|March 27, 2012
The role of CUGBP1 in age-dependent changes of liver functionsKarlie Jones, Lubov Timchenko, Nikolai A Timchenko
Seminars in Cancer Biology|September 21, 2010
Intracellular signaling and hepatocellular carcinomaPolina Iakova, Lubov Timchenko, Nikolai A Timchenko
Rare Diseases (Austin, Tex.)|July 9, 2014
GSK3β is a new therapeutic target for myotonic dystrophy type 1Christina Wei, Karlie Jones, Nikolai A Timchenko, et al.
Aging|February 17, 2010
GSK3beta and aging liverJingling Jin, Guo-Li Wang, Lubov Timchenko, et al.
Pageof 5